Advertisement
YOU ARE HERE: LAT HomeCollectionsSpecial Situation Partners Inc
IN THE NEWS

Special Situation Partners Inc

FEATURED ARTICLES
BUSINESS
November 1, 2001 | Bloomberg News
A dissident shareholder group demanded that ICN Pharmaceuticals Inc. speed its restructuring and questioned management's intentions to follow through on a planned breakup of the Costa Mesa drug maker. The group, Special Situation Partners Inc., outlined its questions in a letter to ICN Chief Executive Milan Panic. ICN last week said third-quarter profit was far short of analysts' estimates because royalties fell for ribavirin, a component it licenses to Schering-Plough Corp.
ARTICLES BY DATE
Advertisement
BUSINESS
June 29, 2000 | From Bloomberg News
A European investment group that has been pressuring ICN Pharmaceuticals Inc. to split into three separate companies has increased its holdings in the Costa Mesa drug maker. Since June 14, Special Situation Partners Inc. bought 185,000 ICN shares for $4.8 million, an average of $25.95 a share, according to a report filed Wednesday with the Securities and Exchange Commission. The investor now holds 2.6 million shares, 3.3% of ICN, as well as options to buy 3.
BUSINESS
August 29, 2000 | From Bloomberg News
An investment group says it may nominate its own slate of directors for ICN Pharmaceuticals Inc. in a move to pressure the Costa Mesa drug maker to change a planned restructuring. Special Situation Partners Inc., which owns about 8.5% of ICN, also is talking with "several" companies that might be interested in buying pieces of ICN, Eric Knight, managing director of the investment group, said Monday in an interview.
Los Angeles Times Articles
|